Question 1

What is Neffy?

Accepted Answer

Neffy is a Other.

Question 2

How often does Neffy appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 6 articles.

Question 3

When was Neffy first tracked by Ergen?

Accepted Answer

First tracked on Jun 26, 2026.

Question 4

When was Neffy last mentioned in news?

Accepted Answer

Last active on Jul 01, 2026.

Question 5

What is Neffy's current news sentiment?

Accepted Answer

Aggregate sentiment score: -40 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Neffy in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Neffy?

Accepted Answer

ARS Pharmaceuticals Securities Investigation (Jun 26, 2026, 6 articles).

Question 8

How did the "ARS Pharmaceuticals Securities Investigation" event impact Neffy?

Accepted Answer

Neffy is ARS Pharmaceuticals' flagship epinephrine nasal spray, whose lack of new commercial formulary additions triggered the investigation and the company's stock decline.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.